Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Saxagliptin Added to Dapagliflozin and Metformin in T2DM
NCT02304081Phase 4Completed
- Start
- Jan 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in type 2 diabetes mellitus (T2DM). Started Jan 2015; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02304081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02304081.